Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-06-10
Original SEC Filing: Click here

---

Webplus: CBPO/20150610/8-K/2_EX-1.1/000.htm SEC Original: v412877_ex1-1.htm
EXECUTION VERSION CHINA BIOLOGIC PRODUCTS, INC. UNDERWRITING AGREEMENT June 10, 2015 June 10, 2015 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, N.Y. 10010 Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 Jefferies LLC 520

---

---

Webplus: CBPO/20150610/8-K/3_EX-5.1/000.htm SEC Original: v412877_ex5-1.htm
June 10, 2015 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3ASR (No. 333-204761) (“the Common Stock Preferred Stock Units Selling Stockholders Selling Stockholder Securities Securities Prospectus Prospectus Supplement Shares Underwriting Agreement We understand that 3,000,000 shares of Common Stock of which

---

---

Webplus: CBPO/20150610/8-K/4_EX-99.1/000.htm SEC Original: v412877_ex99-1.htm
China Biologic Announces Pricing of Public Offering of Common Stock BEIJING, China – June 10, 2015 The Company intends to use the proceeds from the offering primarily for general corporate purposes. In addition, if appropriate opportunities arise in the future to acquire or invest in complementary businesses, products or technologies, the Company may use a portion of the net proceeds

---

---

Webplus: CBPO/20150610/8-K/1/000.htm SEC Original: v412877_8k.htm

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-06-10CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125